AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 161 min read$IBEX

Ballou-Aares Daniella sold $60K of IBEX

Ballou-Aares Daniella sold 1,500 shares of IBEX Ltd (IBEX) at $40.29 on 2026-09-15.

Original reporting
SEC EDGAR · Ballou-Aares Daniella
Published Sep 16, 2026, 9:50 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 9:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$IBEX
Neutral
medium confidence
Mentioned
$IBEX
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IBEXNeutralLow
01

Why it matters

The disclosed sale is modest and does not suggest material adverse information.

02

Market read

Minor insider transaction with limited trading relevance.

03

What to watch

No additional corporate events or market conditions were disclosed.

Relevance 3/10Novelty 4/10Timing: filed today

Background

Form 4 filing reports insider transactions; directors' sales are monitored for potential signals.

Company-level read

Ticker impact

$IBEXNeutralMedium confidence
Context

Director Ballou-Aares Daniella sold 1,500 shares for $60,436, reducing her stake to 10,395 shares.

Expected impact

Potential slight downward pressure, but likely negligible.

Evidence & confidence

Sale size is small relative to float and does not indicate material information.

Market effects

Sector

None

Regional

None

Global

None

Counterpoint

What could challenge this read

The sale could be routine portfolio rebalancing, not a negative signal.

Key entities

  • Company
    IBEX Ltd

    Issuer of the shares sold.

  • Insider
    Ballou-Aares Daniella

    Director of IBEX Ltd who sold shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

IBEX insider trading history →

Related articles

SEP 13
$IBEXHighAI 8/10

IBEX (IBEX) Turns The AI Threat Into Its Biggest Growth Engine

IBEX (IBEX) reported record full-year revenue of $644.1M, up 15.4%, and Q4 revenue of $164.3M, up 11.6%. Growth was driven by HealthTech, Technology, and Travel & Logistics. AI partnerships with Philippine Airlines and BJ's Wholesale showed strong results. Q4 net income fell to $8.7M, and EPS dropped to $0.59 due to training and operational costs.

yahoo.com2 min
SEP 11
$IBEXMedAI 8/10

IBEX (IBEX) Q4 2026 Earnings Call Transcript

IBEX (IBEX) reported fiscal year 2026 revenue of $644.1 million, up 15.4%, with Q4 revenue at $164.3 million, up 11.6%. Adjusted EBITDA reached $82.4 million, a 14.5% increase. HealthTech revenue grew 38.5% to $114 million. Guidance for 2027 projects revenue of $700M-$715M and adjusted EBITDA of $90M-$94M. The company highlighted growth in AI-powered services and strategic partnerships.

aol.com2 min
SEP 10
$IBEXHigh

IBEX Reports Record Fiscal Year 2026 Financial Results, Introduces Fiscal Year 2027 Guidance

IBEX Ltd (IBEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 IBEX Reports Record Fiscal Year 2026 Financial Results, Introduces Fiscal Year 2027 Guidance • Record fourth quarter revenue grew 12% versus prior year quarter, sixth consecutive quarter of double-digit growth • Nine new logo wins in the fourth quarter, including two

SEC EDGAR 8-K3 min